Statin Therapy To Limit Cognitive Dysfunction After Cardiac Surgery

Status Withdrawn

Clinical Trial Summary

The primary aim of our prospective, randomized, double-blind interventional clinical trial is to determine the effectiveness of high dose atorvastatin therapy to reduce post operative cognitive dysfunction (POCD) in patients undergoing cardiac valve surgery. We hypothesize that therapy with high dose atorvastatin will significantly reduce the incidence and/or severity of POCD.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Basic Science

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01186289
Study type	Interventional
Source	Duke University
Contact
Status	Withdrawn
Phase	N/A
Start date	October 2010
Completion date	October 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04005456` - Personalized Lifestyle Intervention for Improving Functional Health Outcomes Using N-of-1 Tent-Umbrella-Bucket Design	N/A
Enrolling by invitation	`NCT06227962` - Cognitive Functioning and Health Related Quality of Life in Retinoblastoma Survivors
Completed	`NCT04038788` - Add-on HD Hf-tRNS Over Bilateral DLPFC for Treating Patients With Schizophrenia	N/A
Recruiting	`NCT05077748` - An 18-year Follow-up Study on OSA in a Population-based Cohort
Recruiting	`NCT03709199` - Long Term Follow up of Children Enrolled in the REDvent Study
Recruiting	`NCT03606421` - CBF and NCF Changes With Brain Radiation
Recruiting	`NCT04458207` - Cognitive Changes and Neural Correlates After Rehabilitation of Masticatory Function in Elderly -an Intervention Study	N/A
Recruiting	`NCT05363332` - Impact and Sequelae of High Ventilatory Drive in Critically Ill COVID-19 Patients
Recruiting	`NCT03886675` - Intervention With Cerebral Embolic Protection in TEVAR: Gaseous Protection	N/A
Enrolling by invitation	`NCT04373525` - Prospective Evaluation on Cognitive Function and Its Associated Genetic Vulnerability in Cannabis Users
Enrolling by invitation	`NCT04881266` - Long-Term Functional, Quality-of-Life, Neuropsychological and Cognitive Outcomes in COVID-19 Critical Illness Survivors
Completed	`NCT03795454` - Can Singing Kangaroo Improve Outcome of Preterm Infants	N/A
Recruiting	`NCT05019300` - Long-term Neurocognitive and Psychiatric Consequences in Severe COVID-19 Survivors.
Not yet recruiting	`NCT05245903` - Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
Terminated	`NCT03163277` - Using Less Neurotoxic Drugs in Patients With HAND (MARAND-X)	Phase 4
Not yet recruiting	`NCT06224088` - Neuro-cognitive Function 1 Year Post ICU Discharge Among VV ECMO Survivors
Completed	`NCT03460821` - Validation of a German Translation and Cultural Adaptation of the Addenbrooke's Cognitive Examination III
Terminated	`NCT03863639` - Changes in fMRI and Neurocognitive Function in Women With Pre-eclampsia
Enrolling by invitation	`NCT03567304` - Neurocognitive Function Improvement After Switching From Efavirenz to Rilpivirine	Phase 4
Completed	`NCT03368352` - Effects of Melatonin on Sleep, Ventilatory Control and Cognition at Altitude.	Early Phase 1